Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC

Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC

Background: Hepatocellular carcinoma (HCC) is the world’s second most deadly cancer, and metabolic reprogramming is its distinguishing feature. Among metabolite profiling, variation in amino acid metabolism supports tumor proliferation and metastasis to the most extent, yet a systematic study on the...

Full description

Bibliographic Details
Main Authors:	Yajuan Zhao, Junli Zhang, Shuhan Wang, Qianqian Jiang, Keshu Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	amino acid metabolism gene prognosis immune infiltration nomogram hepatocellular carcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.731790/full

Similar Items

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
by: Weihao Kong, et al.
Published: (2020-09-01)

Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients
by: Bo-Hao Zheng, et al.
Published: (2018-11-01)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
by: Chen K, et al.
Published: (2021-03-01)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
by: Chenghui Zhou, et al.
Published: (2021-09-01)

A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma
by: Qian Yan, et al.
Published: (2021-05-01)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
by: Qiuxian Zheng, et al.
Published: (2021-06-01)

Antioxidant Gene Signature Impacts the Immune Infiltration and Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
by: Xueting Ren, et al.
Published: (2021-08-01)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
by: Tian-Hao Li, et al.
Published: (2021-05-01)

Using Tumor-Infiltrating Immune Cells and a ceRNA Network Model to Construct a Prognostic Analysis Model of Thyroid Carcinoma
by: Fan Zhang, et al.
Published: (2021-06-01)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
by: Shanshan Liu, et al.
Published: (2021-09-01)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
by: Ye Nie, et al.
Published: (2021-09-01)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
by: Zhijie Xu, et al.
Published: (2021-09-01)

A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
by: Dingde Ye, et al.
Published: (2021-09-01)

Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection
by: Liying Ren, et al.
Published: (2021-07-01)

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
by: Chuan Hu, et al.
Published: (2020-06-01)

Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection
by: Zhang W, et al.
Published: (2019-05-01)

A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer
by: Cheng Guo, et al.
Published: (2021-08-01)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
by: Danjun Song, et al.
Published: (2020-07-01)

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
by: Cai, J., et al.
Published: (2022)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
by: Yiming Luo, et al.
Published: (2021-05-01)

Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma
by: Rui Shen, et al.
Published: (2021-02-01)

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Chang Gon Kim, et al.
Published: (2019-09-01)

A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes
by: Chen Xiong, et al.
Published: (2020-01-01)

Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma
by: Dongsheng He, et al.
Published: (2021-05-01)

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
by: Li-xiang Zhang, et al.
Published: (2021-03-01)

Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
by: Bo Hu, et al.
Published: (2020-10-01)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
by: Lu Yin, et al.
Published: (2021-02-01)

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches
by: Huaping Chen, et al.
Published: (2021-01-01)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
by: Yuan Nie, et al.
Published: (2021-03-01)

Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma
by: Susu Zheng, et al.
Published: (2021-03-01)

Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
by: Zhu J, et al.
Published: (2021-08-01)

A novel five‐gene signature predicts overall survival of patients with hepatocellular carcinoma
by: Zhigang Wang, et al.
Published: (2021-06-01)

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
by: Chen Xue, et al.
Published: (2021-09-01)

Development and Validation of a Prognostic Nomogram to Predict the Long-Time Prognosis in Non-B, Non-C Hepatocellular Carcinoma
by: Lin K, et al.
Published: (2020-08-01)

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients
by: Guosheng Yuan, et al.
Published: (2021-01-01)

Two predictive precision medicine tools for hepatocellular carcinoma
by: Zhiqiao Zhang, et al.
Published: (2019-11-01)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
by: Qian‐Wen Rao, et al.
Published: (2020-11-01)

A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma
by: Du X, et al.
Published: (2021-03-01)

Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
by: Hu B, et al.
Published: (2020-11-01)

KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma
by: Xiuzhi Zhang, et al.
Published: (2020-10-01)